
Why Ophthalmology
Ophthalmology's Quiet Comeback: The Independent Practice Resurgence
For most of the last 2 decades, the story in American medicine has run in one direction. Independent practices consolidate into larger groups, larger groups sell to hospital systems or private equity platforms, and physician ownership steadily declines year over year. That story is still true in aggregate, and nobody serious disputes the overall trend line. It's no longer the only story taking shape underneath the headline numbers, and the counter-trend forming there deserves considerably more attention than it's currently getting from most observers.
Direct primary care and concierge-style independent practice have grown steadily for more than a decade now, tracked consistently by physician membership organizations like the American Academy of Family Physicians. The growth started in primary care, where the economics of independence are simplest to execute, but the underlying motivation driving it, physicians wanting more control over how they practice than employment or large-platform ownership currently allows them, isn't a primary-care-specific sentiment confined to one corner of medicine. It shows up everywhere physicians have been asked what they want, and it shows up in specialty medicine just as clearly as it shows up in family practice, once anyone bothers to look for it there.
What's Driving Ophthalmology's Independent Practice Comeback
The consolidation wave of the last 2 decades promised physicians scale, negotiating leverage, and administrative relief in exchange for reduced day-to-day autonomy. For many physicians, that trade delivered exactly what it promised on the label, and those physicians remain satisfied inside larger platforms today. For a growing number of others, it didn't deliver as promised, particularly once the platforms making that promise were structured around a finite hold period that required an eventual sale, sometimes more than once in succession, to a new owner with priorities different from the ones the physician originally signed on for years earlier.
Every time a platform changes hands, the physicians inside it experience a small reset of trust that accumulates over time. New priorities arrive, sometimes new leadership, occasionally new compensation structures, all imposed on people who didn't choose any of it and had no seat at the table when it happened. Enough of those resets, spread across enough of the industry over enough years, produce a population of physicians who have directly experienced what a lack of long-term alignment actually feels like from the inside, not as an abstract concern but as a lived pattern repeating itself. That population isn't shrinking on its own. It's the natural byproduct of an industry built around structures explicitly designed to eventually be sold to someone else.
Why This Ophthalmology Trend Looks Different From Past Independence Movements
Physicians have always had some baseline appetite for independence, going back well before the current consolidation wave began. What's different about the current moment is that the appetite is now backed by infrastructure that simply didn't exist a decade ago. Management service organizations built specifically to handle the operational burden that used to make independence impractical for most physicians. Dedicated billing and revenue cycle platforms that didn't exist in their current form even 5 years ago. Technology that lets a small practice run the back office functions that once required a much larger organization to support efficiently at any reasonable cost.
This matters because it changes what independence costs a physician in time and personal risk, which is the entire calculation that used to make independence a hard sell. A decade ago, choosing independence over employment or platform ownership meant taking on the operational burden personally, exactly the burden most physicians correctly want no part of managing themselves. Today, a physician choosing independence within a properly built management structure isn't taking on that burden at all, because someone else is handling it competently, which means the old trade-off, control versus workload, no longer accurately describes the actual choice sitting in front of them the way it once did.
What the Ophthalmology Resurgence Signals for the Next Decade
None of this suggests platform and PE-backed models are disappearing from the specialty, and they aren't, nor should anyone expect them to be. For some physicians and some markets, that structure remains the right fit, and will likely stay that way for a long time. What it does suggest is that the assumption driving most of the last 2 decades, that consolidation is the inevitable endpoint and independence is a fading relic of an older era, no longer holds up cleanly against what's happening on the ground in real markets today. A meaningful and growing share of physicians are actively choosing structures that preserve independence precisely because those structures no longer require the personal sacrifices independence used to demand of anyone who wanted it.
The ophthalmologists most likely to be part of this shift aren't necessarily the ones already vocally opposed to consolidation on principle. They're often the ones who tried the alternative firsthand, watched a platform change hands once or twice over a few years, and started asking a new question, what a structure built for permanence rather than an eventual sale would actually look like in practice. That question didn't have a good, concrete answer a decade ago. It increasingly does now, and the physicians asking it are finding real options where there used to be none worth considering.
What Ophthalmology's Comeback Looks Like on the Ground
The resurgence rarely announces itself the way the consolidation wave did, with large public transaction announcements and press releases. It shows up instead in smaller, quieter signals that add up over time if anyone bothers to track them. A physician turning down a platform offer that would have been an easy yes 5 years earlier. A young doctor asking, in an interview, whether a practice's management structure has ever been sold, and how many times. A retiring owner deliberately seeking a permanent-hold buyer instead of taking the highest bid from a platform planning its own eventual exit. None of these moments make headlines individually, and none of them show up in a quarterly report anywhere, which is exactly why the shift has been so easy for the industry to miss. Together, across enough practices and enough markets over enough years, they describe a real and lasting change in what physicians are willing to accept, and what they're actively seeking out instead.
This matters for anyone evaluating where the specialty is headed over the next decade, not just the next fiscal quarter. A trend built on individual physicians reassessing what they want, backed by infrastructure that finally makes the alternative practical, tends to be considerably more durable than a trend built on financial engineering that depends on continuously favorable capital markets to keep working as designed. Durability, in the end, is the entire argument, because a structure that only works while capital is cheap was never really built for the physicians relying on it in the first place. The physicians choosing independence today are, in effect, choosing to bet on themselves over the next full cycle rather than on whoever happens to be holding the paper when that cycle eventually turns against them.
Educational material only. Figures are illustrative and individual results vary. Images are AI-generated illustrations and don't depict actual Verdira practices, physicians, or patients. See our Disclosures.
Written by
Verdira Team
Verdira is building a permanent home for ophthalmology practices. We write about succession, physician ownership, and the forces reshaping eye care in the United States.
Ready to secure your legacy?
We're here to ensure your hard work is valued and your business thrives as part of Verdira.
Disclosures
The content of this site is for general informational purposes only and is not intended to constitute an offer to sell or a solicitation to buy any security or other asset, or a promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.
The content of this site is for general informational purposes only and is not intended to constitute an offer to sell or a solicitation to buy any security or other asset, or a promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.
The content of this site is for general informational purposes only and is not intended to constitute an offer to sell or a solicitation to buy any security or other asset, or a promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.
© 2026 Verdira Management NY, LLC
